))
Genomic Test Helps Decide Which DCIS Needs Radiation
Manage episode 388333490 series 3525104
Kandungan disediakan oleh Breastcancer.org. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Breastcancer.org atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
The Oncotype DX Breast DCIS Score test is used to help people and their doctors make decisions about whether radiation after lumpectomy surgery to remove DCIS would offer more benefits than risks.
At the 2023 San Antonio Breast Cancer Symposium, Dr. Seema Khan presented results from the E4112 study, evaluating the ability of the Oncotype DX Breast DCIS Score to accurately predict which women would benefit from radiation after DCIS surgery and which women could safely skip radiation.
Listen to the podcast to hear Dr. Khan explain:
the design of the study, including why a prospective study is important
the results
how the results fit into the current context of DCIS care
303 episod
Kongsi
